News
Opinion
Culture & Lifestyle
Community
Business & Tech
Judaism
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Times of Israel Partner
subscribe
Open search field
Open menu button
Search the site
Search query
Clear search input
search
Subscribe to our newsletter
Today’s top stories
– trusted, exclusive,
straight to your inbox.
Subscribe
Email address
Subscribe
The email is either missing or invalid
Search the site
Search query
Clear search input
search
Close menu
News
Opinion
Culture & Lifestyle
Community
Business & Tech
Judaism
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Times of Israel Partner
Donate
Competitions
Job board
Spotlight
E-editions
Jewish News
Magazines
About Us
About Us
Contact Us
Advertise with Us
Where to Find Us
Terms and Conditions
Privacy Policy
Follow us
Facebook
Instagram
Tiktok
Twitter
Youtube
Linkedin
Bluesky
Subscribe to our newsletter
Today’s top stories
– trusted, exclusive,
straight to your inbox.
Subscribe
Email address
Subscribe
The email is either missing or invalid
© 2026 JewishNews, All Rights Reserved.
Concept, design & development by
Powered by
Salamandra
Sheba Medical Center Pancreatic Cancer Center
June 6, 2019, 11:41 am
Israeli cancer breakthrough ‘doubles life expectancy’
New drug developed to treat specific type of pancreatic cancer in people who carry BRCA mutation, which is more prevalent among Ashkenasi Jews than the general population
By
Stephen Oryszczuk
Load More
